↓ Skip to main content

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma

Overview of attention for article published in BMC Cancer, January 2011
Altmetric Badge

Mentioned by

peer_reviews
1 peer review site

Citations

dimensions_citation
114 Dimensions

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
Published in
BMC Cancer, January 2011
DOI 10.1186/1471-2407-11-33
Pubmed ID
Authors

Amanda Tivnan, Lorraine Tracey, Patrick G Buckley, Leah C Alcock, Andrew M Davidoff, Raymond L Stallings

Abstract

Neuroblastoma is a paediatric cancer which originates from precursor cells of the sympathetic nervous system and accounts for 15% of childhood cancer mortalities. With regards to the role of miRNAs in neuroblastoma, miR-34a, mapping to a chromosome 1p36 region that is commonly deleted, has been found to act as a tumor suppressor through targeting of numerous genes associated with cell proliferation and apoptosis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Belgium 1 1%
Brazil 1 1%
Unknown 66 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 23%
Student > Master 12 17%
Student > Ph. D. Student 12 17%
Student > Bachelor 9 13%
Other 4 6%
Other 10 14%
Unknown 7 10%
Readers by discipline Count As %
Agricultural and Biological Sciences 22 31%
Biochemistry, Genetics and Molecular Biology 18 26%
Medicine and Dentistry 13 19%
Engineering 4 6%
Neuroscience 2 3%
Other 4 6%
Unknown 7 10%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2014.
All research outputs
#15,302,068
of 22,757,541 outputs
Outputs from BMC Cancer
#4,106
of 8,276 outputs
Outputs of similar age
#141,810
of 182,685 outputs
Outputs of similar age from BMC Cancer
#27
of 35 outputs
Altmetric has tracked 22,757,541 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,276 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 182,685 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.